Recently, a new type of transmembrane protein with a unique combination of protein domains was characterized from human, rabbit and chicken. This protein exhibits features of the low-density lipoprotein receptor family and shows homology to the receptor of the neuropeptide head activator isolated from hydra. To study the temporal and spatial pattern of expression of this unusual new receptor we have isolated a murine homolog and, in accordance with its human counterpart, named it mSorLA. Northern blot analysis revealed the highest abundance of mSorLA transcripts in the adult brain, lower levels in a variety of other organs and expression during embryogenesis. In situ hybridization showed predominant localization in neurons of the cortex, the hippocampus and the cerebellum. During embryonic development mSorLA displayed a unique pattern of expression in the cerebral cortex, where a subpopulation of neurons was labeled before final differentiation. Transcripts of mSorLA were also detected outside the central nervous system in regions active in morphogenesis.
Introduction
Recently, a new type of mosaic protein was discovered as a member of the low-density lipoprotein-receptor (LDLR) family in vertebrates (Jacobsen et al., 1996; Yamazaki et al., 1996; Mörwald et al., 1997) . This protein consists of a single transmembrane domain, a short cytoplasmic carboxy terminus and a large extracellular part containing a domain with homology to the yeast sorting protein VPS10 (Marcusson et al., 1994) and regions characteristic for members of the LDLR family (Yamamoto et al., 1984) followed by fibronectin type III domains (Bork et al., 1996) . Unique for this new type of protein is the alignment of extracellular domains, so far never found in this order and combination in other receptors.
The vertebrate receptor, named SorLA (sorting-protein related receptor containing LDLR class A repeats) by one group and LR11 by another, was identified in human, rabbit and chicken (Jacobsen et al., 1996; Yamazaki et al., 1996; Mörwald et al., 1997) and was shown to bind apolipoprotein E-containing lipoproteins as extracellular ligands (Yamazaki et al., 1996) and the LDLR-associated protein RAP as intracellular ligand (Jacobsen et al., 1996) . The region with homology to the LDLR family consists of cysteine-rich repeats and EGF-precursor domains which show greatest homology to the LDLR-related protein (LRP) and to megalin. Both proteins are important for development and maintenance of function of the nervous system and bind various ligands, some of which mediate neurite outgrowth (Kounnas et al., 1995) or modulate hippocampal neurite development (Narita et al., 1997) . The importance of megalin for the development of the nervous system is underlined by the fact that knockout mice suffer from defective forebrain development (Willnow et al., 1996) .
To gain insight into the role this new receptor might play during development, we cloned a mouse homolog, mSorLA, and analyzed its expression pattern in developing mouse embryos and in adult mice. Highest expression levels were detected in the differentiating and adult nervous system. Notably in the developing cerebral cortex, but not in other regions of the telencephalon, mSorLA marked subpopulations of newborn neurons before their final differentiation. Transcripts were detected during periods of active morphogenesis, suggesting a role for this receptor in the growth and differentiation of many embryonic tissues.
Results

mSorLA is mainly expressed in the adult brain and during embryonic development
The cDNA sequence of mSorLA was obtained by performing polymerase chain reaction (PCR) with degenerate and gene-specific primers on murine cDNA and by screening the database of expressed sequence tags (EST). The translated amino-acid sequence revealed the same combination and alignment of domains as are found in the other vertebrate homologs. The overall amino acid identity is 94% to human SorLA.
We analyzed the transcript distribution of mSorLA in adult tissues by Northern blot analysis. As Fig. 1A shows, the highest transcript levels were detected in the brain, where two bands were labeled, one of Ͼ10 kb and another of 8 kb representing 80% and 20% of the total signal, respectively. Both mRNA sizes were also found in heart, lung, skeletal muscle and kidney, whereas no signals were detected in liver. In lung and kidney the 8 kb transcript was more abundant than the Ͼ10 kb species. In skeletal muscle an additional faint band of about 6 kb was detected. To ensure that the observed bands were not due to cross-hybridization, we hybridized the same filter with a fragment derived from the overlap between the VPS10 domain and the LDLR class B repeat region, characteristic for SorLA, and obtained the same results (data not shown). Therefore, we conclude that the different transcript sizes are due to alternative splicing, usage of multiple transcription start sites or differential polyadenylation.
We also investigated whether mSorLA is expressed during embryonic development. While at embryonic day 7 (E7) no hybridizing bands appeared, the highest labeling intensity was seen at E11 (Fig. 1B) . As in the adult, two transcripts of Ͼ10 kb and of 8 kb, respectively, were observed.
mSorLA is highly expressed in specific regions of the adult brain
To investigate the distribution of the mSorLA transcripts in the adult central nervous system we performed in situ hybridization on frozen sections of adult mouse and rat brain. No differences in hybridization pattern were seen between these two species. Fig. 2 shows high levels of mSorLA transcripts over the cerebral cortex, the pyramidal cells of the CA region of the hippocampus, the granular cells of the dentate gyrus, the Purkinje cell layer of the cerebellum ( Fig. 2A ) and the piriform cortex (Fig. 2B) . Lower transcript levels were detected over the mitral cell layer of the olfactory bulb (data not shown), the nuclei of the amygdala, the nucleus reticularis of the thalamus and several hypothalamic nuclei (Fig. 2B ). In the brainstem the pontine nuclei were also weakly labeled (data not shown). Even prolonged exposure times did not reveal any hybridization signals over the striatum.
Analysis of emulsion-dipped sections revealed a pattern typical for neuronal expression (Fig. 2C-J) . High densities of silver grains were detected over neurons in the cerebral cortex (Fig. 2C,D) with highest signal intensity in layer 5, containing pyramidal cells (Fig. 2E) . Intense hybridization was also observed over the pyramidal cells of the CA regions (Fig. 2F ) and the granular cells in the dentate gyrus of the hippocampus (Fig. 2C,D) and over the Purkinje cells in the cerebellum (Fig. 2G,H) . Fiber tracts and areas with a high content of glial cells did not exhibit hybridization. Fig. 2I ,J shows that this also holds for the retina, where only the ganglion cell layer exhibited hybridization. Neuronal expression of mSorLA was further confirmed by the fact that we did not detect co-localization with transcripts encoding the glial fibrillary acidic protein (data not shown). We conclude from these data that mSorLA is specifically expressed in some but not all neuronal populations of the adult brain. (I,J) section through an adult rat retina; scale bar is 50 mm for E,F,G,I. am, amygdala; CA1, CA3, region of the hippocampal pyramidal cell layer; cb, cerebellum; cc, cerebral cortex; dg, dentate gyrus; gcl, ganglion cell layer; gl, granular cell layer; hi, hippocampus; hy, hypothalamus; inl, inner nuclear layer; ipl, inner plexiform layer; ml, molecular layer; pc, Purkinje cells; pic, piriform cortex; py, pyramidal cell layer; rt, reticular nucleus.
mSorLA is widely expressed during early embryogenesis
We analyzed the expression of mSorLA during early development by in situ hybridization starting at E5.5. The first hybridization signals were detected in the area of the postamniotic fold at E6.5 (Fig. 3A,B) . In sections of E7.5 embryos, mSorLA transcripts were observed over the entire embryo, with the exception of the ectoplacental cone and were especially abundant in the amnion (Fig. 3C,D) . Up to E8.5 the expression further increased and became more restricted to the foregut and the amnion (Fig. 3E,F) . No signal was seen over the neural plate. At E9.5 the somites, as well as the developing gut, were marked by increasing labeling intensities ( Fig. 3G-I ). Signals were also observed over the facial-cranial mesenchyme and the branchial Fig. 3 . Expression of mSorLA during early embryogenesis. Sections through embryos at E6.5 (A,B), E7.5 (C,D) and E8.5 (E,F) were hybridized with a 35 Slabeled riboprobe and are shown as brightfield views revealing the histology (A,C,E) and corresponding darkfield photomicrographs with the signal grains in white (B,D,F). (G-I) Expression of mSorLA at E9.5 is shown as whole-mount in situ hybridization (G) and as histological section in bright-field (H) and dark-field view (I). (J-P) Expression of mSorLA at E10.5 is shown in J as whole-mount in situ hybridization using a DIG-labeled riboprobe and sections K-P hybridized with the radioactively-labeled probe. Higher magnifications of the hind-brain region (M,N) and of the spinal cord (O,P) at E10.5 are shown. Scale bar is 0.5 mm; a, amnion; ba, branchial arch; c, chorion; drg, dorsal root ganglia; ec, ectoplacental cone; fg, foregut; fm, facial mesoderm; hg, hindgut; m, mesenchyme; mn, motor neurons; mz, marginal zone; nc, neural canal; np, neural plate; pf, postamniotic fold; ov, otic vesicle; sc, spinal cord; so, somite; vz, ventricular zone; IV, fourth brain ventricle.
arches (Fig. 3G ). As seen in Fig. 3J -L the hybridization signal in the mesenchyme and the somites reached its maximal intensity at E10.5. In contrast to earlier stages, strong labeling was observed over the ventral part of the neural tube where the just differentiating motor neurons reside and it extended throughout the hindbrain ( Fig. 3K-P) . As these signals were confined to the marginal zone of the neural tube, and since no signals were detected over the heavily-stained ventricular area, we conclude that only postmitotic neural cells express the mSorLA gene. Again, as in the adult, not all neural cells exhibited hybridization signals. The dorsal root ganglia, containing neural cells at a similar stage of differentiation to the motor neurons in the spinal cord, were not marked by mSorLA expression (Fig. 3O,P) .
In summary, the expression pattern of mSorLA changed drastically during early embryonic development. With the appearance of postmitotic, differentiating neurons, mSorLA transcripts were detected at high levels in specific locations of the neuroectoderm which had not shown expression at earlier stages.
Restricted expression of mSorLA in the developing telencephalon
As already shown in Fig. 3M -P, mSorLA expression in the nervous system was first apparent at E10.5 in highlyspecific locations in the spinal cord and the hindbrain. With ongoing development, the brain became the main location of mSorLA expression (Fig. 4A ,B,E,F). Here, mSorLA transcripts were seen in the telencephalon at E11.5, being restricted to the lateral aspects of the developing cerebral cortex, decreasing dorso-laterally (Fig. 4A,B ). Close to, or at the midline of the telencephalon, no transcripts were detected. The cells that showed this strong hybridization signal were located in the outer layer of the neuronal tissue of the developing cerebral cortex, where neurons which have just left the adjacent proliferative ventricular zone reside (Fig. 4C,D) . No transcripts were detected in other parts of the telencephalon. Up to E14.5 the signal in the developing cerebral cortex became more even and spread to more dorsal and caudal locations (Fig. 4A,E ,F,G-J), following the direction of ongoing differentiation in the cerebral cortex (Bayer and Altman, 1991) . Other areas of the telencephalon, like the septum, the striatum and even the olfactory bulb, where differentiation of mitral cells had already begun at E11.5, did not exhibit any hybridization signals ( Fig. 4A-J) .
At E16.5 accumulation of mRNA was observed over the entire cortical area, although at a slightly lower intensity (Fig. 4A ). Two areas with strong hybridization signals became distinguishable, the subventricular zone and the outer aspects of the cortical plate (Fig. 5A-D) . While at this stage weak hybridization signals were observed over the mitral cell layer of the olfactory bulb (Fig. 5A,B,E,F) , other derivatives of the telencephalon, like the striatum, did not exhibit any signals (Fig. 5A-F) .
Until the day of birth (P0), the overall signal intensity in the cortex further decreased (Fig. 4A) . At E18.5 the outer aspects of the cortical plate were still more weakly labeled than the subventricular zone (Fig. 5G,H) . In contrast, at P0 hybridization signals in the outer aspects of the cortical plate were more intense than those in the subventricular zone (Figs. 4A and 5I-L). Other regions of the telencephalon, with the exception of the olfactory bulb and the hippocampal formation, were unlabeled. This indicates that the adult pattern of expression of mSorLA in the cerebral cortex is determined early during embryonic development.
mSorLA is expressed in specific central neuronal populations outside the telencephalon
Although the cerebral cortex of the telencephalon was the brain region with the highest mSorla transcript abundance, other areas of the central nervous system expressed the gene as well. Already at E10.5, motor neurons of the spinal cord and the ventral areas of the hindbrain exhibited hybridization signals ( Fig. 3M-P) . By E11.5, the most intense labeling was seen in the myelencephalon where from E10.5 onwards many newborn neurons expressed mSorLA (Fig.  4A,C,D) . Transcripts were also detected in a thin cell layer in the rhombic lip of the metencephalon (Fig. 4C,D) . Already at E14.5, a decrease in labeling intensity in the metencephalon and the myelencephalon was observed (Fig. 4A,G,H) . Weak hybridization signals in the mesencephalon and the diencephalon were observed, beginning at E12.5 (data not shown). In the hypothalamus, labeling just above background was seen at E16.5 (Fig. 5E,F) . In the retina and the geniculate nucleus of the thalamus, transcripts were detected at E18.5 with increasing intensity towards P0 (data not shown and Fig. 5I-L) .
Late onset of mSorLA expression in the peripheral nervous system
The formation and differentiation of the peripheral ganglia begins around E9. Transcripts of mSorLA were detected in the peripheral nervous system, starting at E16.5. The labeling intensity was low compared with the signals observed in the central nervous system. We could identify mSorLA transcripts in the trigeminal ganglion, the dorsal root ganglia (Fig. 6A-D) , the cochlear-vestibular ganglia and the sympathetic ganglia chain (data not shown). Hybridization was also detected between the two outer walls of the gut, where the enteric ganglia reside ( Fig. 8M-P) .
Expression of mSorLA outside the nervous system suggests multiple developmental functions
The expression of mSorLA outside the nervous system was maintained after E10.5, although mostly at lower levels than in the central nervous system. Of the different glands, the label was detected in the pituitary (Figs. 7A-D and 5G- Photoemulsion-dipped sagittal section through the head of an E14.5 embryo. (I,J) Coronal section through the forebrain region at the level of the diencephalon at E14.5. Scale bar is 2 mm; bl, bladder; cc, cerebral cortex; drg, dorsal root ganglia; fm, facial mesoderm; gb, genital bud; ki, kidney; lu, lung; mes, mesencephalon; me, metencephalon; my, myelencephalon; ne, nasal epithelium; pa, pancreas; re, rectum; sc, spinal chord; sg, sereous gland; sm, submandibular gland; st, striatum; th, thyroid gland; u, urethra. (A,B) , coronal (C,D) and sagittal (E,F) sections through the head region of an E16.5 embryo. (G,H) Sagittal section through the head at E18.5. Sagittal (I,J) and coronal (K,L) sections through the head at P0. Scale bar is 2 mm; cb, cerebellum; cc, cerebral cortex; gn, geniculate nucleus; hi, hippocampus; ob, olfactory bulb; pi, pituitary; pn, pineal gland; st, striatum. J), the pineal (Figs. 5E,F and 7E,F), the thyroid (Fig. 7G,H ) and the Haderian gland of the eye (Fig. 7I,J) . In addition, transcripts were present in the serous glands of the nasal cavity (Figs. 4A and 5G,H) , the salivary and the submandibular gland (Fig. 4A ). In the abdomen the pancreas was labeled (Fig. 4A) .
A variety of organs and tissues expressed mSorLA differentially during embryonic development. The expression in the genital bud, the mesenchymal tissue, the developing skeletal muscles and the myocardium of the heart was seen early during organogenesis, and it decreased below detection levels during further development ( Fig. 3G-P,  Figs. 4B-F and 8A,B) .
The primitive gut, which expressed mSorLA already at E8.5 (Fig. 3E,F) , gives rise to a variety of organs. Many of these rely on epithelial-mesenchymal interactions for induction of morphogenesis. We detected mSorLA transcripts in a variety of organs already at E11.5. Examples for this are seen in Fig. 8A-D,I ,J. The epithelia of the stomach, the tubules of the kidney, the tooth germ, the cochlea, the nasal cavity, the trachea, the lung, the bladder and urethra, the intestine and the rectum were labeled, although with declining intensities throughout the analyzed stages of development ( Fig. 8C-P; Fig. 4A ; data not shown). The endothelia lining the blood vessels, for example the aorta (Figs. 7G,H and 8O,P), never showed hybridization and the same was true for the choroid plexus (Fig. 5E-J) . In the thymus, the liver and the spleen very faint spotty signals were detected after prolonged exposure times on dipped sections starting from E16.5 (data not shown).
Discussion
In the present study we isolated a murine homolog of human SorLA and studied its expression in the adult mouse and during embryonic development. This receptor is characterized by a unique combination of protein domains which is conserved in homologs from human, rabbit, chicken (Jacobsen et al., 1996; Yamazaki et al., 1996; Mörwald et al., 1997) and now also from mouse. The extracellular part of the protein contains a domain with the characteristic signatures of a sorting protein from yeast (Marcusson et al., 1994) with unknown function as yet in higher organisms. This module is followed by a region with features common to members of the LDLR family, containing cysteine-rich (Fass et al., 1997) and EGF precursor-like repeats (Yamamoto et al., 1984) . The cysteine-rich repeats were shown to be responsible for the binding of multiple Fig. 6 . Expression of mSorLA in the developing peripheral nervous system. Sagittal sections at E16.5 through the trigeminal ganglion (A,B) and at E18.5 through the dorsal root ganglion (C,D) are shown. Scale bar is 0.2 mm; ao, aorta; bb, basiphenoid bone; drg, dorsal root ganglion; tri, trigeminal ganglion. Fig. 7 . Expression of mSorLA in developing glands. Sagittal sections through the pituitary gland at E12.5 (A,B) and at the day of birth (C,D), horizontal section through the pineal gland at E16.5 (E,F), sagittal section through the thyroid gland at E18.5 (G,H) and horizontal section through the Haderian gland at the day of birth (I,J). Scale bar is 0.2 mm; ao, aorta; Hg, Haderian gland; pi, pituitary gland; pn, pineal gland; pt, parathyroid gland; r, retina; sp, sphenoid cartilage; t, thymus; th, thyroid gland.
ligands. Some authors suggest that the number of cysteinerich repeats present in a receptor molecule may reflect the number of ligands (Brown et al., 1997) .
In mSorLA, the LDLR-homologous region is followed by fibronectin type III domains as they have been described in cell-adhesion molecules like e.g. N-CAM or some members of the protein tyrosine kinase-receptor family. Fibronectin type III domains were shown to be involved in cell-cell and protein interactions.
Northern blot analysis revealed the highest transcript levels of mSorLA in the adult brain, but also weaker expression in other organs. This is in good agreement with data reported for other species (Jacobsen et al., 1996; Yamazaki et al., 1996; Mörwald et al., 1997) . In situ hybridization studies showed that mSorLA is prominently expressed in discrete areas of the adult brain, namely the cerebral cortex, the hippocampus and the Purkinje cells of the cerebellum. Its transcripts were absent from areas containing fiber tracts indicative of a purely neuronal expression pattern. The distribution of the mSorLA protein in the cerebrum of rabbits as analyzed by immunohistochemistry supports this notion (Mörwald et al., 1997) .
During development, the central nervous system was the main location of mSorLA expression. High transcript levels were found in areas where cells have migrated out from the proliferative zone. Although differentiation in the central nervous system proceeds in general in a caudal to rostral fashion, the highest abundance of mSorLA transcripts was observed in the developing telencephalon. Accumulation of transcripts in the cortical zone of the telencephalon was found at E11.5, as soon as the first neurons of the cerebral cortex become postmitotic (Gardette et al., 1982) . In contrast, some areas, like the striatum, never exhibited hybridization signals, and in others transcripts were only detected late, such as in the olfactory bulb, where transcripts were first detected at E16.5 although differentiation of neurons had started earlier. It has been shown that while neural progenitor cells are able to move within both dorsal cortical and basal striatal ventricular zones, they are unable to cross the boundary area between them (Fishell, 1995) . This hints at the existence of molecular and cellular signals that establish the borders between cortical and basal zones. The differential expression of mSorLA in the developing telencephalon could point to an involvement in this process.
We observed a decrease of mSorLA transcript levels in the subventricular zone coincident with an increase in the outer aspects of the cortical plate between E16.5 and P0. Fig. 8 . Expression of mSorLA in developing organs. Sagittal sections through the heart at E11.5 (A,B), the stomach at E11.5 (C,D), the lung at E12.5 (E,F) and at E14.5 (G,H), the kidney at E11.5 (I,J) and E14.5 (K,L), the abdomen at E16.5 (M,N) and the gut at E18.5 (O,P). Scale bar is 0.2 mm; ao, aorta ; bl, bladder; br, bronchiole; g, glomerulus; he, heart; hg, hindgut; in, intestine; li, liver; lu, lung; m, metanephros; mg, midgut; re, rectum; st, stomach; u, urethra. The most likely explanation for this is that mSorLA is expressed in neurons migrating from the subventricular zone to the outer zone during cortical reorganization (Allendoerfer and Shatz, 1994) .
The appearance of mSorLA transcripts in some neuronal populations of the spinal cord, the myelencephalon, the metencephalon and the telencephalon followed the general directions of ongoing neuronal differentiation. However, mSorLA is not a general marker for the differentiation of neurons. For example, in the cerebellum only the Purkinje cells or in the olfactory bulb only the mitral cells exhibited hybridization signals.
In most areas of the central nervous system we observed a decrease in overall hybridization intensities during development, which was especially obvious in the developing metand myelencephalon. In the cerebellum anlage we detected strong hybridization signals at E11.5 which most probably originated from Purkinje cells (Hatten et al., 1997) . At E14.5 the Purkinje cells lie interspersed between other newborn neurons and the overall hybridization intensity was much lower. As soon as the Purkinje cells are arranged in a discrete area at E16.5, the strong hybridization signal reappeared. Therefore, we presume that the observed reduction in overall signal intensity may be due to dilution by non-expressing cells, rather than to reduced transcription rates in individual populations.
mSorLA expression during embryonic development was also detected outside the nervous system. We found mSorLA transcripts during early organogenesis of a variety of glands and organs, some of which rely on epithelialmesenchymal interactions for their proper development, e.g. lung and kidney. These data indicate a role of mSorLA in the establishment of embryonic organ systems.
The fact that mSorLA transcripts were detected in organs during their early phases of morphogenesis and in some still at their fully differentiated state makes it likely that mSorLA may serve different functions depending on the time point and location of expression.
Recently, a protein was isolated from the coelenterate hydra by its ability to bind the neuropeptide head activator. The partial peptide sequence shows homology to vertebrate SorLA (Franke et al., 1997) . Preliminary data suggest identical alignment and order of protein domains (unpublished data). The major difference between the invertebrate and the vertebrate proteins is the lower number of repeats, which may reflect the lower number of ligands in the primitive organism. Head activator was shown to stimulate head specific growth and differentiation processes in hydra . In mammals, a peptide of identical sequence (Bodenmüller and Schaller, 1981) was found during early development of the nervous system and of neuroendocrine organs and is still present in adults. Its functions in mammals include the stimulation of proliferation of neuronal precursor cells, stabilization of nerve cell survival and enhancement of neurite outgrowth (Kajiwara and Sato, 1986; Schaller et al., 1989a,b; Quach et al., 1992; Niemann and Schaller, 1996) . Although it has yet to be shown that vertebrate SorLA binds head activator, the pattern of expression suggests a morphogenetic function which is compatible with a possible role as a head-activator receptor.
Methods
Cloning of the mSorLA cDNA
By PCR on mouse brain cDNA with degenerate primers from a conserved region in the VPS10 domain and one in the sixth EGF-precursor repeat of the hydra head-activator receptor and human and chicken SorLA, 839bp of mSorLA were amplified.
The first 144 bp of the known mouse cDNA were obtained by screening a mouse genomic P1 library with oligonucleotides.
Three murine EST-clones (IMAGp998A05813, IMAGp-998K151911, IMAGp998K241768 with the accession numbers w42320, AA267402, AA276210) were identified by homology to the 3 end of SorLA, obtained from the I.M.A.G.E. Consortium (Lehrach, 1990; Lennon et al., 1996) and sequenced.
Sequence information between the different known parts of mSorLA was obtained by PCR on cDNA from the cell line NH15-CA2, a double-hybrid neuroblastoma-glioma cell line where the neuronal part comes from mouse and the glial part from rat (Heumann et al., 1979) and which is a target for HA (Ulrich et al., 1996) . Overlapping information derived from this cell line, mouse brain cDNA and the EST clones was identical.
These sequence data have been submitted to the GenBank under the accession number AF031816.
Northern blot analysis
A mouse multiple tissue Northern blot (Clontech 7762-1) and a mouse embryo Northern blot (Clontech 7763-1) were hybridized with 32 P-labeled probes encoding parts of the VPS10 domain (nucleotides 1-784), the overlap region of the VPS10 domain and the EGF-precursor repeats (nucleotide 1513-2361), or the fibronectin type III domains (nucleotide 5315-6230) of mSorLA with similar results. The blots were washed with 0.1× SSC, 0.05% SDS at 68°C for 1 h. To compare the amounts of mRNA on the filters they were hybridized with the b-actin probe provided by the manufacturer.
In situ hybridization
Fetal and neonatal mice from natural matings between inbred CD-1 mice (Charles River) were collected at the stages indicated. In situ hybridization on frozen sections was performed as described (Bettler et al., 1990) The animals were frozen on solid CO 2 and 10-mm sections were prepared on a cryostat. Adult rat and mouse brains were sectioned at 15 mm. The 35 S-UTP-labeled sense and antisense probes encoded the overlap region of the VPS10 domain and the EGF-precursor repeats (nucleotides 1513-2361) or the fibronectin type III domains (nucleotides 5315-6230) of mSorLA. The hybridized sections were exposed to Kodak Biomax MR film for 3 days, dipped in Kodak NTB-2 nuclear emulsion, exposed for 8 days to 3 weeks and subsequently stained with Giemsa. No signals were detected using the sense probes whereas the antisense probes yielded the same hybridization pattern.
Whole-mount in situ hybridization using Digoxigenin (DIG)-UTP-labeled probes was performed on embryos as described by Rosen and Beddington (1993) and Wilkinson (1992) and modified by Parr et al. (1993) . Up to E10.5, proteinase K treatment was omitted. Transcription reactions were performed using the Ambion transcription kit for the production of radioactive probes and the Boehringer DIGlabeling kit for the production of DIG-labeled probes. Morphological structures in embryonic mice were identified by reference to Rugh (1990) and Kaufmann (1992) .
